ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Holly Lindsay, MD
Children's Hospital Colorado
Study Chair - Maryam Fouladi, MD
Nationwide Children's Hospital
Principal Investigator - Todd C Hankinson, MD
Children's Hospital Colorado
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sydney Children'S Hospital
Randwick, New South Wales, Australia
Recruiting - Queensland Children'S Hospital
South Brisbane, Queensland, Australia
Recruiting - Perth Children'S Hospital
Perth, Western Australia, Australia
Recruiting
- Stollery Children'S Hospital
Edmonton, Alberta, Canada
Recruiting - the Hospital for Sick Children (sickkids)
Toronto, Ontario, Canada
Recruiting - Mcgill University Health Center
Montreal, Quebec, Canada
Recruiting
- Children'S Hospital Colorado
Aurora, Colorado, United States
Recruiting - Children'S National Medical Center
Washington D.C., District of Columbia, United States
Recruiting - Nicklaus Children'S Hospital
Miami, Florida, United States
Active, not recruiting - Duke Children'S Hospital
Durham, North Carolina, United States
Recruiting - Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Recruiting - Nationwide Children'S Hospital
Columbus, Ohio, United States
Recruiting - Texas Children'S Hospital
Houston, Texas, United States
Recruiting - Seattle Children'S Hospital
Seattle, Washington, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Dec 2022
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2029
- Last update posted
- 23 Apr 2026
- Registered enrollment
- 30
- Registry id
- NCT05233397
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.